Should You Buy Clover Health Investments, Corp. Stock in 2026?
According to the CirclFi Deep Alpha Valuation Engine, Clover Health Investments, Corp. (CLOV) occupies a solid middle-ground position with a Quality of Company score of 6.5/10. At the current market price of $4.66, the investment case depends heavily on whether our 13 independent valuation models indicate a discount to fair value.
The short answer: 1 of 2 CirclFi valuation models project upside for Clover Health Investments, Corp. (CLOV) at $4.66 — the models are evenly split, with a Quality Score of 6.5/10 and Value-Trap risk of 32/100. The full bull case, bear case, and risk factors are below. Educational analysis, not financial advice.
What Is the Investment Case for Clover Health Investments, Corp. (CLOV) in 2026?
What Is the Bull Case vs the Bear Case for Clover Health Investments, Corp. (CLOV)?
| Bull case — $4.92 target (+5.5%) | Bear case — $3.82 target (-18.0%) |
|---|---|
| Industry tailwind: regulatory pathway clarity could provide meaningful support for Clover Health Investments, Corp.'s revenue and margin trajectory in the Healthcare Plans space. | According to the CirclFi Deep Alpha Valuation Engine, the FTNN Topology model sees the stock as overvalued with a fair value of $3.82 (-18.0%), suggesting that the market price embeds overly optimistic growth assumptions. |
| Industry headwind: clinical trial failure represents a meaningful risk for Clover Health Investments, Corp. and its Healthcare Plans peers. |
How Does CLOV Compare to Its Healthcare Plans Peers?
Valuation data pages: OSCR · MRAI · ALHC · PGNY · CNC · PFHO · CI · CVS
Which Other Stocks Score Like CLOV on Quality?
Closest companies to CLOV’s Quality of Company score of 6.5/10, across all industries.
- NAII — Natural Alternatives International, Inc. (QOC 6.5) · analysis
- RCAT — Red Cat Holdings, Inc. (QOC 6.5) · analysis
- EDN — Empresa Distribuidora y Comercializadora Norte Sociedad Anónima (QOC 6.5) · analysis
- CLPT — ClearPoint Neuro, Inc. (QOC 6.5) · analysis
- MATW — Matthews International Corporation (QOC 6.5) · analysis
- APD — Air Products and Chemicals, Inc. (QOC 6.5) · analysis
- NVDA — NVIDIA Corporation (QOC 10.0) · analysis
So Is Clover Health Investments, Corp. (CLOV) Worth Buying in 2026?
Clover Health Investments, Corp. at $4.66 is a genuine coin-flip in our framework. The 1–1 bull-bear split across 2 models, +23.4% model spread, and median fair value of $4.37 (-6.2% vs price) argue for a watchlist position rather than a high-conviction bet. Quality at 6.5/10 adds some comfort to the mix.
These are quantitative model outputs, not investment recommendations. Clover Health Investments, Corp.'s future depends on factors — management execution, competitive dynamics, regulatory changes — that no algorithm can fully capture. See all 13 model estimates →
What Else Do Investors Ask About CLOV Stock?
Should I buy CLOV stock right now?
Based on CirclFi's multi-model analysis, 1 of 2 models see upside for CLOV at $4.66. The models are divided, which means the investment case depends heavily on your assumptions about Clover Health Investments, Corp.'s future. This is not a buy recommendation — see our full disclaimer.
What are the biggest risks of investing in Clover Health Investments, Corp.?
Key risks include: limited model coverage (2/13 active), reducing analytical confidence; general market and sector-specific risks affecting Healthcare Plans companies. Always diversify and consult a financial advisor.
How does CLOV compare to its competitors?
Among Healthcare Plans peers, CLOV holds a Quality Score of 6.5/10. Comparable companies include OSCR (QOC 7.1), MRAI (QOC 4.2), ALHC (QOC 7.2). The relative ranking helps investors identify whether CLOV offers better fundamental quality than alternatives in the same sector.
Is CLOV a good long-term investment?
Long-term investment potential depends on fundamental quality and sustainable competitive advantages. CLOV's Quality Score of 6.5/10 suggests moderate fundamentals — not a clear long-term hold without further research into growth catalysts. Check our full data page for all 13 model estimates.
What price should I buy CLOV at?
CirclFi does not provide target buy prices or price alerts. However, our 2 active models produce fair value estimates ranging from $3.82 to $4.92. At $4.66, the stock trades within the range of model estimates. Many value investors look for a 20-30% margin of safety below intrinsic value before buying.
Want the complete picture?
See all 13 model estimates, confidence scores, and the full valuation table for CLOV.
Disclaimer: This article is produced by the CirclFi Valuation Engine using quantitative models and is for educational and informational purposes only. It is not financial advice, a buy/sell recommendation, or a solicitation to trade securities. Past performance is not indicative of future results. All data sourced from SEC EDGAR, FRED, and GDELT. Consult a licensed financial advisor before making investment decisions. Full disclaimer →
Buy with Gumroad